Answers are grounded in this paper and cite their sources.
To assess the anatomical and functional outcomes in eyes with persistent diabetic macular oedema (pDME) on chronic anti-vascular endothelial growth factor therapy switched to intravitreal faricimab.
No takes yet. Share an insight, caveat, or question.
Durrani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: